T 0840/07 (Immunomodulatory peptide/CELLACT PHARMA) of 14.09.2011
- European Case Law Identifier
- ECLI:EP:BA:2011:T084007.20110914
- Date of decision
- 14 September 2011
- Case number
- T 0840/07
- Petition for review of
- -
- Application number
- 02777137.7
- IPC class
- C07K 14/705A61K 38/18A61P 37/06
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Peptides capable of modulating immune response
- Applicant name
- CellAct Pharma GmbH
- Opponent name
- -
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 82European Patent Convention R 103(1)(a)European Patent Convention R 44(1)
- Keywords
- Unity of invention (yes)
Remittal (yes)
Reimbursement of appeal fee (no) - Catchword
- -
- Cited cases
- -
- Citing cases
- T 0487/13
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the department of first instance for further prosecution on the basis of claims 1 to 10 of the main request filed with the notice of appeal dated 16 February 2007.
3. The request for reimbursement of the appeal fee is refused.